-
Sansheng Pharmaceutical HIF-PH Inhibitor HIF-117 Capsule (SSS17) Approved clinical
Time of Update: 2020-06-07
recently, it was revealed that the Three Pharmaceutical (http:// HIF-PH inhibitor HIF-117 capsule (SSS17) was approved for clinical treatment of anemia in patients with chronic kidney disease Th
-
AstraZeneca Selumetinib capsules submit clinical applications in China
Time of Update: 2020-06-07
today, it was revealed that AstraZeneca's Selumetinib capsule suised clinical applications in the country Selumetinib filed an application for new drug (http:// to treat patients with type 1 neu
-
FDA approves application for kit for rapid diagnosis of Ebola virus disease
Time of Update: 2020-06-07
Ebola virus is a generic term used to refer to several viruses belonging to the virus, which belongs to the fibrous virus EVD, which is usually transmitted through blood and fluid, is a potent infec
-
European Commission approves Novartis anti-inflammatory drug Cosentyx (good, secukinumab) label update
Time of Update: 2020-06-07
, Swiss Pharmaceuticals (http:// giant Novartis announced that the European Commission (EC) has approved an update to the label of the anti-inflammatory drug Cosentyx (secukinumab) The label upda
-
Lilly Taltz (ixekizumab) Phase 3 trial reaches primary and secondary ends
Time of Update: 2020-06-07
recently, Lilly (http:// announced that its IL-17A inhibitor Taltz (ixekizumab) had reached the main end and all critical secondary endpoints in the of test (http:// treating patients with sev
-
FDA approves a license application for complementary biologics from Airbnb Botox
Time of Update: 2020-06-07
Recently, Allergan announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has approved a supplementary biologic license application (sBLA) for Botox (patos," generic name
-
FDA accepts New Drug Listing Request from Zogenix for Fintepla (ZX008)
Time of Update: 2020-06-07
Dravet syndrome, also known as infant severe myoclonic epilepsy (SMEI), is a rare, refractory epilepsy Zogenix (http:// announced that the u.S FDA (http:// has accepted the company's applicat
-
FDA accepts new drug application from Incyte's FGFR1/2/3 inhibitor pemigatinib
Time of Update: 2020-06-07
today, incyte (http:// announced that the U.S FDA (http:// has accepted its FGFR1/2/3 inhibitor pemigatinib new drug (http:// application (NDA) for the treatment of patients with late-stage
-
Concord Kirin announces launch of Parkinson's new drug Nourianz in US
Time of Update: 2020-06-07
recently, Japan Pharmaceutical Company Concord and Kirin announced the launch of the new Parkinson's drug (http:// Nourianz (http:// in the United States Nourianz was approved by the U.S FDA (
-
FDA approves Novo nordisk Fiasp (Mendon Insulin Injection) 100u/mL label extension
Time of Update: 2020-06-07
recently announced that the U.S Food and Drug (http:// Administration http:// (http:// has approved the Fiasp (Mendin insulin injection ) 100u/mL label extension Fiasp is a quick-acting insuli
-
Application for new drug for green leaf pharmaceutical injection leipaketone reprieve microsphere (LY03004) accepted by the National Drug Review Center
Time of Update: 2020-06-07
Recently, the Group of Green leaf Pharmaceutical (http:// announced that its independent research and development of innovative preparation "injectable lypeone re-release microsphere (LY03004)"
-
GlaxoSmithKline's long-lasting triple inhalation agent "Full Re-Le" gets listing approval from China's State Drug Administration
Time of Update: 2020-06-07
Today, GlaxoSmithKline (GSK) announced that Trelegy ® Ellipta ®, a long-acting triple inhalation agent for slow-obstructed lung stabilization, has been approved by the Regulatory Authority of china
-
Red Sun Pharmaceuticals' declared innovative drug Emediffen tablets approved for solid cancer clinical trials
Time of Update: 2020-06-07
recently, Red Day Pharmaceuticals issued a notice, received the National Drug Administration issued a clinical trial (http:// notice, company (http:// declared new drugs (http:// amedifyfen
-
FDA approves a new indication for Alexion's Lourtomiris (ravulizumab-cwvz)
Time of Update: 2020-06-07
recently, Alexion (http:// announced that the U.S Food and Drug (http:// Administration (http:// http:// has approved a new indication of Ululizumab-cwvz for the treatment of atypical hemol
-
FDA grants Roche's preferred review
Time of Update: 2020-06-07
, Roche announced that the u.S FDA (http:// has accepted and qualified for priority review of new drug (http:// About Risdiplam Risdiplam is an mRNA shear modifier for the SMN2 gene for spin
-
FDA approves Xtandi extended indications
Time of Update: 2020-06-07
Today, Astellas and Pfizer (http:// announced that the U.S FDA (http:// approves Xtandi (enzalutamide) to extend the indications to treat patients with metastatic hormone-sensitive prostate ca
-
NICE approves Pfizer's cancer drug Ibrance combined fluorovis group for treatment of patients with localized advanced or metastatic breast cancer
Time of Update: 2020-06-07
recently, Pfizer announced that the National Institute sequinor (NICE) http:// has approved the acquisition of the targeted anti-cancer drug Ibrance (Aboxin, Palbociclib, pyroxici), a combination
-
Phase 3 clinical trial of AstraZeneca's Imfinzi (durvalumab) reaches primary and sub-end
Time of Update: 2020-06-07
Today, AstraZeneca company (http:// announced that its PD-L1 monoclonal antibody Imfinzi (durvalumab) and chemotherapy-based combination therapy, with the addition of anti-CTLA-4 antibodies tre M
-
Phase 3 clinical trial of Abbvie Rinvoq (upadacitinib) for psoriasis arthritis reaches primary and secondary endpoint
Time of Update: 2020-06-07
today, AbbVie (http:// announced that its JAK1-specific inhibitor, Rinvoq (upadacitinib), reached the primary and primary secondary end of the trial in the Phase 3 clinical trial (http:// SELE
-
FDA approves RedHill antibiotic drug Talicia for treatment of adult patients infected with Helicobacter pylori
Time of Update: 2020-06-07
recently, (http:// of bio pharmaceutical (http:// announced that its http:// of the antibiotic drug was approved for the fda (http:// to treat adult patients infected with Helicobacter pyl
